Prominent examples of protein cancer biomarkers include prostate-specific antigen (PSA) for prostate cancer screening and early detection of disease recurrence or cancer antigen 125 (CA125) which is used for the surveillance of ovarian cancer recurrence [7–9]. This evidence concerns the gene MUC16 and ovarian carcinoma.